Hopefully finding a bottomIRON ORE DAILY: Liquidity remains limited amid Chinese holiday
Seaborne iron ore prices were largely flat on Tuesday September 21 with limited trading activity in the physical market taking place amid a Chinese holiday.
Fastmarkets iron ore indices
62% Fe fines, cfr Qingdao: $93.03 per tonne, up $0.05 per tonne
62% Fe low-alumina fines, cfr Qingdao: $93.96 per tonne, down $0.11 per tonne
58% Fe fines high-grade premium, cfr Qingdao: $64.87 per tonne, up $0.14 per tonne
65% Fe Brazil-origin fines, cfr Qingdao: $117.50 per tonne, down $0.10 per tonne
- Forums
- ASX - By Stock
- FEX
- Price of Iron Ore
Price of Iron Ore, page-419
-
- There are more pages in this discussion • 1,281 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
BOE
Uranium prices on the NYMEX are stable, but ASX uranium stocks are sinking on Friday. The answer lies in Kazakhstan
NEWS
Week 31 Wrap: JORC rules to get tougher; RBA rate hike chance 50/50; US Fed Sept cut still the quo
NEU
Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
NEWS
Is oil undervalued?
Add FEX (ASX) to my watchlist
|
|||||
Last
37.0¢ |
Change
0.010(2.78%) |
Mkt cap ! $257.0M |
Open | High | Low | Value | Volume |
36.5¢ | 37.8¢ | 36.0¢ | $952.0K | 2.582M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 74237 | 37.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
37.5¢ | 336700 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 74237 | 0.370 |
5 | 114039 | 0.365 |
14 | 389200 | 0.360 |
7 | 455566 | 0.355 |
18 | 392434 | 0.350 |
Price($) | Vol. | No. |
---|---|---|
0.375 | 336700 | 3 |
0.380 | 67624 | 2 |
0.385 | 60000 | 1 |
0.390 | 101920 | 2 |
0.395 | 34000 | 1 |
Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
Featured News
NEWS
Week 31 Wrap: JORC rules to get tougher; RBA rate hike chance 50/50; US Fed Sept cut still the quo
NEU
Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
FEX (ASX) Chart |